Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1997-04-16
1999-09-28
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 31685
Patent
active
059589027
ABSTRACT:
Application of synthetic or naturally occurring lung surfactant to the posterior pharyngeal region prior to a period of sleep significantly reduces episodes of sleep disturbance resulting in apnea or hypopnea. The present invention provides lung surfactant in a convenient applicator container for easy use and storage. Incidents of oxygen desaturation are reduced, thereby lowering the risks of apnea-associated pathologies.
REFERENCES:
patent: 4826821 (1989-05-01), Clements
patent: 5238920 (1993-08-01), Sarin et al.
patent: 5302581 (1994-04-01), Sarin et al.
patent: 5547937 (1996-08-01), Dhaon et al.
patent: 5569679 (1996-10-01), Jacob
Biosis Abstract 77:189178 (1976). Koch.
Chemical Abstracts 111:127039 (1987). Hibino et al.
Hida, Wataru, "Factors Affecting Upper Airway Patency," Japanese Journal of Thoracic Diseases, 28:1, pp. 22-28, Jan. 1990. (as translated).
Lewis and Jobe, Surfactant and the Adult Respiratory Distress Syndrome, Am. Rev. Respir. Dis., vol. 147, pp. 218-233, 1993. published sufficiently before filing date that the month is not in issue.
Girod et al., Phosphlipid Composition and Surface-Active Properties of Tracheobronchial Secretions from Patients with Cystic Fibrosis and Chronic Obstructive Pulmonary Disease, Pediatric Pulmonology vol. 13, pp. 22-27 (1992). published sufficiently before filing date the month is not in issue.
Witek and Schachter, Pharmacology and Therapeutics in Respiratory Care, W.B. Saunders Co., pp. 334-336, 1994. published sufficiently before filing date that the month is not in issue.
Merrit and Halliday, On Exogenous Surfactant Therapy, Pediatric Pulmonology, vol. 14 pp. 1-3, 1992. published sufficiently before filing date that the month is not in issue.
Miki et al., Effects of Pharyngeal Lubrication on the Opening of Obstructed Upper Airway, J. Applied Phys., vol. 72, pp. 2311-2316, 1992. published sufficiently before filing date that the month is not in issue.
T. Van der Touw, The Role of Synthetic Surfactant in Promoting Upper Airway Patency During Negative Airway Pressure in Awake Subjects, Am. J. Respir. Crit. Care Med, vol. 149, p A865, 1994. published sufficiently before filing date that the month is not in issue.
Widdicombe and Davies, The Effects of a Mixture of Surface-active Agents (Sonarex) on Upper Airways Resistance and Snoring in Anaesthetized Dogs, Eur. Respir. J. vol. 1, pp. 785-791, 1988. published sufficiently before filing date that the month is not in issue.
Hoffstein et al., Reduction in Snoring with Phosphocholinamin, a Long-acting Tissue-lubricating Agent, Am. J. Otolaryngol, vol. 8, pp. 236-240, 1987. published sufficiently before filing date that the month is not in issue.
Badr M. Safwan
Meyer Keith C.
Fay Zohreh
Wisconsin Alumni Research Foundation
LandOfFree
Method and composition for treating sleep apnea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treating sleep apnea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating sleep apnea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-703316